WestEnd Advisors’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.54K Hold
12
﹤0.01% 119
2025
Q4
$3.28K Buy
12
+3
+33% +$815 ﹤0.01% 122
2025
Q3
$2.43K Buy
9
+1
+13% +$272 ﹤0.01% 142
2025
Q2
$2.21K Sell
8
-3
-27% -$816 ﹤0.01% 139
2025
Q1
$2.92K Buy
11
+4
+57% +$987 ﹤0.01% 129
2024
Q4
$1.63K Hold
7
﹤0.01% 110
2024
Q3
$1.54K Buy
7
+1
+17% +$207 ﹤0.01% 101
2024
Q2
$1.18K Buy
6
+5
+500% +$1.03K ﹤0.01% 111
2024
Q1
$215 Buy
+1
New +$210 ﹤0.01% 241
2022
Q1
Sell
-4
Closed -$939 111
2021
Q4
$913 Buy
+4
New +$880 ﹤0.01% 116
2021
Q3
Hold
0
113
2021
Q2
Hold
0
104

Other funds holding CME

WestEnd Advisors's CME Position: Q1 2026 in Review

WestEnd Advisors held its CME Group (CME) position steady in Q1 2026 at 12 shares worth $3.54K. The position accounts for ﹤0.01% of the portfolio, ranked #119.

WestEnd Advisors first reported a position in CME in Q4 2021 and has held it in 10 quarters since. 1,790 funds tracked by Wall St. Rank hold CME as of Q1 2026.

  • WestEnd Advisors held 12 shares of CME Group worth $3.54K as of Q1 2026.
  • WestEnd Advisors left its CME Group share count unchanged in Q1 2026.
  • CME Group made up ﹤0.01% of WestEnd Advisors's portfolio in Q1 2026, its #119 holding.
  • WestEnd Advisors first reported a position in CME Group in Q4 2021 and has held it in 10 quarters since.
  • 1,790 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on WestEnd Advisors's 13F filing for Q1 2026, filed 22 Apr 2026.